Germany is facing serious challenges in the health and pharmaceutical industry, which are reducing trust in this sector due to political instability. In the pharmaceutical industry, the development of new technologies and medical advancements requires significant investments and high risk tolerance. However, instability in laws and policies can disrupt these efforts.
Risk and Uncertainty in the Pharmaceutical Industry
Developing a new drug typically takes between 10 to 15 years and requires billions of euros in research and development investment. Nevertheless, the likelihood of failure in this process is over 90 percent. This risk is part of the business model of the pharmaceutical industry, which is based on innovation. However, political instability can severely impact this process.
The Impact of Policies on the Pharmaceutical Industry
Recent political discussions highlight the contradiction between supportive promises and actual actions. While the German government has emphasized support for the pharmaceutical industry in the coalition agreement, actions such as setting fixed prices and mandatory discounts undermine these promises. Such actions can lead to reduced trust in the industry and negative effects on employment and innovation.
This lack of trust can gradually lead to the decline of an industry. In fact, reduced trust in the pharmaceutical industry signifies the beginning of a vicious cycle that will have negative impacts on the economy and the healthcare system. Therefore, there is a need for a fundamental change in approach that focuses on supporting innovation and investment in the pharmaceutical industry rather than financial issues.
Opportunity for Change
Currently, German politicians have the opportunity to adopt a new approach. New proposals from an expert commission have been presented that could help companies investing in Germany to be exempt from certain financial burdens. These proposals aim to create a more sustainable and encouraging system for the pharmaceutical industry.
Therefore, to restore trust in the pharmaceutical industry and create an effective strategy for the future, Germany needs serious and sustainable actions. These actions will not only benefit the pharmaceutical industry but ultimately benefit the entire economy and society.
